readthroughSign in
CompanyENTXNasdaqJerusalem

Entera Bio Ltd.

Entera Bio develops oral peptide and protein replacement therapies using its N-Tab® technology platform.

8-KNov 16Latest SEC filing
Nov 6Latest story